The $2 Trillion Valuation Debate Skips What Anthropic Knows 
Pharmacore secures funding to improve medication regimen reviews in long-term care Indonesia’s Bio Farma ready to produce ‘IndoVac’ Covid-19 vaccines
BANDUNG, INDONESIA, Sep 12, 2022 – (ACN Newswire) – PT Bio Farma, the holding company…
Axiom Exhibiting at SCDM 2022 Annual Conference
TORONTO, Sept. 11, 2022 (GLOBE NEWSWIRE) — Axiom Real-Time Metrics (“Axiom”), the premier provider of…
Late Breaking Data Presented at ESMO Congress 2022 Demonstrate Potential of RLY-4008 to Transform Treatment Options for Cholangiocarcinoma Patients with FGFR2-Driven Disease
88% overall response rate (15 out of 17) from interim data of pan-FGFR treatment (FGFRi)-naïve FGFR2-fusion…
Public Sector Retirement Educators Launch FERS Planning & Training Platform
Public Sector Retirement Educators has launched an ADA-compliant online platform that provides federal employees, at…
Golden Tax Relief Enters Top 500 Of Inc. 5000’s Fastest Growing Businesses
Ranked No. 410, Golden Tax Relief has entered the top 500 of Inc. 5000’s list…
CENTRESTAGE showcases talent of local designers
HONG KONG, Sep 11, 2022 – (ACN Newswire) – Asia’s leading fashion event CENTRESTAGE draws…
SpringWorks Therapeutics Announces Data from Phase 3 DeFi Trial Evaluating Nirogacestat in Adult Patients with Progressing Desmoid Tumors at the European Society for Medical Oncology (ESMO) Congress 2022
– Nirogacestat Treatment Resulted in Rapid, Sustained and Statistically Significant Improvements in Primary and All…
Presents Positive Safety and Efficacy Data from the Completed Phase 1 Dose Escalation Cohort of ICT01 plus Pembrolizumab in the EVICTION Trial at ESMO Congress 2022
Broad antitumor immune responses and demonstration of durable disease control from solid tumor patients who…
Apexigen Presents New Data from a Phase 2 Trial Evaluating its CD40 Antibody, Sotigalimab, in Combination with Neoadjuvant Chemoradiation in Patients with Resectable Esophageal and Gastroesophageal Junction Cancers at ESMO Congress 2022
-Sotigalimab in combination with neoadjuvant chemoradiation induced higher pathologic complete response rates, an important predictor…
Cabaletta Bio Presents New Interim Data from the DesCAARTes™ Phase 1 Trial at the 31st EADV Congress
PHILADELPHIA, Sept. 10, 2022 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology…
CENTRESTAGE ELITES unveils latest fashion trends
HONG KONG, Sep 10, 2022 – (ACN Newswire) – Organised by Hong Kong Trade Development…
KBRA Releases Marketplace Consumer Loan Indices for August 2022; Announces Tier 2 Index Constituent Changes
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases its marketplace consumer loan indices for August 2022, providing monthly credit…
Exai Bio Presents Data Demonstrating that its Novel RNA-based Liquid Biopsy Platform has Potential for Early Detection and Monitoring of Colorectal Cancer
– Poster presentation at the 2022 Annual Meeting of the European Society of Medical Oncology…
Adagene Presents Interim Monotherapy Data at ESMO 2022 Showing Compelling Safety, Anti-Tumor Activity and Pharmacokinetics of Masked, Anti-CTLA-4 SAFEbody® ADG126 in Patients with Advanced Tumors
– Best-in-class profile demonstrated with repeat dosing across dose levels – – Antitumor activity observed…
Anaveon presents updated data from the Phase I/II study of ANV419 during the ESMO Congress 2022
– ANV419 is well-tolerated at high doses and demonstrates notable safety with strong pharmacodynamic effects…
Novartis Cosentyx® shows clinically meaningful symptom improvements in patients with hidradenitis suppurativa in pivotal Phase III trials
Results from two parallel trials show Cosentyx® (secukinumab) demonstrated superior efficacy vs placebo with statistically…
Domain Authority, Google Indexing & Marketing Service Launched By LinkDaddy
LinkDaddy has announced a new update to its digital marketing service to help businesses increase…
Verizon Response: Planned power outages in CA and OR
IRVINE, Calif., Sept. 09, 2022 (GLOBE NEWSWIRE) — We know how important it is to…
Solar America Continues Industry Leadership With Inc. 5000 2022 Award Ranking
Superior Revenue Growth Earns Coveted Recognition Among America’s Fastest-Growing Companies DENVER–(BUSINESS WIRE)–#alternativeenergy—Solar America, the leading…
Chalice Brands Ltd. Announces Termination of Totem Farms & Miracle Greens Transactions
PORTLAND, Ore., Sept. 09, 2022 (GLOBE NEWSWIRE) — Chalice Brands Ltd. (CSE: CHAL) (OTCQB: CHALF)…